Aprameya EngineeringNSE:APRAMEYA -1.15%43 Net Margin % is 9.25% as of Mar. 2026, which is 51% above its 10-year median of 6.12. GuruFocus rates NSE:APRAMEYA with a GF Score™ of 43/100. The stock has 5 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Aprameya Engineering ranks better than 77.48% on this metric.
The historical rank and industry rank for Aprameya Engineering's Net Margin % or its related term are showing as below:
NSE:APRAMEYA'
s Net Margin % Range Over the Past 10 Years
Min: 3.32 Med: 6.12 Max: 11.88
Current: 11.88
NSE:APRAMEYA's Net Margin % is ranked better than 77.48% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.09
vs NSE:APRAMEYA: 11.88
Aprameya Engineering (NSE:APRAMEYA) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Aprameya Engineering Net Margin % Related Terms
Aprameya Engineering Net Margin % Historical Data
* Premium members only.
The historical data trend for Aprameya Engineering's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:APRAMEYA vs ISRG, BDX, MDLN: Net Margin % Comparison
For the Medical Instruments & Supplies subindustry, Aprameya Engineering's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aprameya Engineering Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aprameya Engineering's Net Margin % distribution charts can be found below:
* The bar in red indicates where Aprameya Engineering's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aprameya Engineering (NSE:APRAMEYA) has a Net Margin % of 9.25% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Aprameya Engineering and its competitors. This is 51% above median its historical median of 6.12. Over the past decade, Aprameya Engineering's Net Margin % has ranged from 3.32 to 11.88. According to the industry distribution chart, Aprameya Engineering ranks #184 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 22.5%.
Is Aprameya Engineering's Net Margin % too high?
Aprameya Engineering's current Net Margin % of 9.25% is 51% above median its 10-year median of 6.12. Over the past 10 years, this metric has ranged from a low of 3.32 to a high of 11.88. The Medical Devices & Instruments industry median Net Margin % is 2.09. Aprameya Engineering's value of 9.25% is 342.6% above this industry median. Based on the distribution chart, Aprameya Engineering ranks #184 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Aprameya Engineering has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Aprameya Engineering's Net Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Aprameya Engineering ranks #184 out of 817 companies for Net Margin %. This places Aprameya Engineering in the top 23% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.09. Aprameya Engineering's value of 9.25% is 342.6% above this benchmark. Historically, Aprameya Engineering's own Net Margin % has ranged from 3.32 to 11.88 over the past decade. While the company's 10-year median is 6.12 vs. the industry median of 2.09, Aprameya Engineering has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.09, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aprameya Engineering's current Net Margin % of 9.25% is 342.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Aprameya Engineering and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aprameya Engineering's current Net Margin % is 9.25%, which is 51% above median its own 10-year median of 6.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprameya Engineering stock overvalued right now?
Aprameya Engineering (NSE:APRAMEYA) has a current Net Margin % of 9.25%. The current Net Margin % is 9.25%, which is 51% above median its 10-year median of 6.12 and 342.6% above the Medical Devices & Instruments industry median of 2.09. Aprameya Engineering's overall GF Score™ is 43/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Aprameya Engineering (NSE:APRAMEYA), the current Net Margin % is 9.25% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aprameya Engineering Ltd is engaged in the business of installation, set up & maintenance of Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatre, dialysis centres and prefabricated structure ward (hereinafter referred to as Healthcare Infrastructure projects) in the hospitals and medical care centers on turnkey basis with the supply of high-value healthcare equipment and diagnostic equipment to private hospitals, Government hospitals, and medical practitioners. The company has two Business segments: Trading of Medical support Equipment (Trading Sales) and Supplies for Infra Projects for health care sectors (Turnkey project supplies). Key revenue is generated from Trunkey Project Supply.
43GF Score
Get the complete analysis for NSE:APRAMEYA
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:APRAMEYA has been successfully added to your 